Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) is a step closer to acquiring Cephalon, Inc. (NASDAQ:CEPH) with the US Federal Trade Commission (FTC) accepting the proposed consent order in connection with the acquisition. The FTC has also granted early termination of the Hart Scott Rodino waiting period.
Conditions Laid Down by the FTC
However, the FTC has laid down certain conditions related to the completion of the acquisition. Firstly, Teva will have to divest two abbreviated new drug applications … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards